Share on LinkedInShare on LinkedIn

ARTICLE · 16 NOVEMBER 2012

Supreme Court Invalidates Pfizer’s Blockbuster VIAGRA® Patent

McCarthy Tétrault
McCarthy Tétrault
Contributor
McCarthy Tétrault

McCarthy Tétrault

McCarthy Tétrault LLP provides a broad range of legal services, delivering strategic and...

View firm profile
Explore more from McCarthy Tétrault

Canada’s top court has struck down Pfizer Inc.’s lucrative patent on VIAGRA, paving the way for generic entry into the Canadian marketplace shortly.

CanadaIntellectual Property

Canada's top court has struck down Pfizer Inc.'s lucrative patent on VIAGRA, paving the way for generic entry into the Canadian marketplace shortly.

In Teva Canada Ltd. v. Pfizer Canada Inc., 2012 SCC 60, the Supreme Court of Canada unanimously (7-0) declared Pfizer's patent for its blockbuster VIAGRA drug invalid on the basis of insufficient disclosure.

Background – the '466 Patent

Pfizer research scientists initially investigated "sildenafil citrate" (VIAGRA's active compound) for use as a cardiovascular drug.  However, upon discovering sildenafil's peculiar effect on rats, scientists began to suspect that the compound might be useful in treating erectile dysfunction (ED).  This suspicion turned out to be correct, and Pfizer's blockbuster drug VIAGRA was invented.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from